Journal of Chinese Integrative Medicine ›› 2004, Vol. 2 ›› Issue (5): 390-395.doi: 10.3736/jcim20040524
• Lecture • Previous Articles Next Articles
CLC Number:
[1] |
Reaven GM . Banting Lecture 1988. Role of insulin resistance in human disease[J]. Diabetes, 1988,37(12):1595-1607
doi: 10.1007/978-94-011-2700-4_10 |
[2] | 李秀钧 . 胰岛素抵抗综合征(第1版)[M]. 北京: 人民卫生出版社, 2001,( 第1版):80-85 |
[3] |
陈蕾, 贾伟平, 陆俊茜 , 等. 上海市成人代谢综合征流行调查[J]. 中华心血管病杂志, 2003,31(12):909-912
doi: 10.3760/j:issn:0253-3758.2003.12.007 |
[4] | Scandinavian Simvastatin Survival Group . Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study(4S)[J]. Lancet, 1994,344(8934):1383-1389 |
[5] |
Haffner SM, Stern MP, Hazuda HP , et al. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary disease start ticking before the onset of clinical diabetes[J]. JAMA, 1990,263(21):2893-2898
doi: 10.1001/jama.1990.03440210043030 |
[6] |
King GL, Brownlee M . The cellular and molecular mechanisms of diabetic complications[J]. Endocrinol Metab Clin North Am, 1996,25(2):255-270
doi: 10.1016/S0889-8529(05)70324-8 |
[7] |
陈灏珠 . 我国人群血脂水平现状和高脂血症的治疗[J]. 中西医结合学报, 2004,2(2):81-82
doi: 10.3736/jcim20040201 |
Chen HZ . Current status of blood lipid level and treatment of hyperlipoidemia in Chinese population[J]. Zhong Xi Yi Jie He Xue Bao, 2004,2(2):81-82 | |
[8] |
DECODA Study Group, International Diabetes Epidemiology Group. Cardiovascular risk profile assessment in glucose-intolerant Asian individuals —an evaluation of the World Health Organization two-step strategy: the DECODA Study(Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Asia)[J]. Diabet Med, 2002,19(7):549-557
doi: 10.1046/j.1464-5491.2002.00735.x |
[9] | 王树海, 王文健 . 胰岛素抵抗的发病机制及中西医结合防治策略[J]. 中西医结合学报, 2004,2(1):14-16 |
Wang SH, Wang WJ . Pathogenesis of insulin resistance and prevention and treatment strategy of integrated traditional Chinese and Western medicine[J]. Zhong Xi Yi Jie He Xue Bao, 2004,2(1):14-16 |
[1] | Zeinab Vafaeipour, Bibi Marjan Razavi, Hossein Hosseinzadeh. Effects of turmeric (Curcuma longa) and its constituent (curcumin) on the metabolic syndrome: An updated review. Journal of Integrative Medicine, 2022, 20(3): 193-203. |
[2] | Dastan M. Khoshnaw, Abhijit A. Ghadge. Yoga as a complementary therapy for metabolic syndrome: A narrative review. Journal of Integrative Medicine, 2021, 19(1): 6-12. |
[3] | Hepatology Committee of Chinese Association of Integrative Medicine, China. Guidelines for diagnosis and treatment of hepatic fibrosis with integrated traditional Chinese and Western medicine (2019 edition). Journal of Integrative Medicine, 2020, 18(3): 203-213. |
[4] | Sonia Chew Wen Phang, Uma Devi Palanisamy, Khalid Abdul Kadir. Effects of geraniin (rambutan rind extract) on blood pressure and metabolic parameters in rats fed high-fat diet. Journal of Integrative Medicine, 2019, 17(2): 100-106. |
[5] | Mehranghiz Ebrahimi-Mameghani, Mohammad Asghari-Jafarabadi, Khatereh Rezazadeh. TCF7L2-rs7903146 polymorphism modulates the effect of artichoke leaf extract supplementation on insulin resistance in metabolic syndrome: A randomized, double-blind, placebo-controlled trial. Journal of Integrative Medicine, 2018, 16(5): 329-334. |
[6] | Reshma M.Ansari. Potential use of durian fruit (Durio zibenthinus Linn) as an adjunct to treat infertility in polycystic ovarian syndrome. Journal of Integrative Medicine, 2016, 14(1): 22-28. |
[7] | Zemin Yao, Li Zhang, Guang Ji. Efficacy of polyphenolic ingredients of Chinese herbs in treating dyslipidemia of metabolic syndromes. Journal of Integrative Medicine, 2014, 12(3): 135-146. |
[8] | Rajadurai Akilen, Zeller Pimlott, Amalia Tsiami, Nicola Robinson. The use of complementary and alternative medicine by individuals with features of metabolic syndrome. Journal of Integrative Medicine, 2014, 12(3): 171-174. |
[9] | Wen-jian Wang. Enhancing the treatment of metabolic syndrome with integrative medicine. Journal of Chinese Integrative Medicine, 2013, 11(3): 153-156. |
[10] | Tian-zhan Wang, Yu Chen, Yan-ming He, Xiao-dong Fu, Wang Yi, Yan-qiu Xu, Hong-jie Yang, Hong-li Xue, Yi Liu, Xiao-tao Feng, Teng Zhang, Wen-jian Wang. Effects of Chinese herbal medicine Yiqi Huaju Qingli Formula in metabolic syndrome patients with microalbuminuria: a randomized placebo-controlled trial. Journal of Chinese Integrative Medicine, 2013, 11(3): 175-183. |
[11] | Yi Chen, De-yu Fu, Yu Chen, Yan-ming He, Xiao-dong Fu, Yan-qiu Xu, Yi Liu, Xiao-tao Feng, Teng Zhang, Wen-jian Wang. Effects of Chinese herbal medicine Yiqi Huaju Formula on hypertensive patients with metabolic syndrome: A randomized, placebo-controlled trial. Journal of Chinese Integrative Medicine, 2013, 11(3): 184-194. |
[12] | Feng Jiang, Lin-chun Fu, Jian-ping Ma, Qing Zhou, Bo Peng, Shi-ping Xie, Hui-jun Guo, Yong-xin Dong, Xiu-lan Ma, Xuan-xian Guo, Zhong-li Xie, Yan-ping Hu, Qing-ya Li, Hua-wei Li, Yan-tao Jin. Traditional Chinese medicine syndrome factors of patients with HIV infection or AIDS in China. Journal of Chinese Integrative Medicine, 2011, 9(9): 955-964. |
[13] | Liang-ping Hu, Xiao-lei Bao, Qi Wang . The repetition principle in scientific research. Journal of Chinese Integrative Medicine, 2011, 9(9): 937-940. |
[14] | Sui Yue Hu, Su E Wang, Chun Hu Zhang. Relationship between symptom stratification and syndrome differentiation of traditional Chinese medicine for depressive episode. Journal of Chinese Integrative Medicine, 2011, 9(9): 933-936. |
[15] | Ci-an Zhang, Pin-kang Wei, Yong-jin Li. Discussion of the correlation between phlegm and tumor microenvironment. Journal of Chinese Integrative Medicine, 2010, 8(3): 215-219. |